ÀÇ·áÁø ã±â
¾Æ·¡ °Ë»öÀ» ÅëÇØ Á¤È®ÇÏ°í ºü¸£°Ô ÀÇ·áÁøÀ» °Ë»öÇÒ ¼ö ÀÖ½À´Ï´Ù.
Ŭ¸®´Ð ¾È³»
Ŭ¸®´ÐÀ» ¾È³»ÇØ µå¸³´Ï´Ù. Ŭ¸¯ ½Ã ÇØ´ç Ŭ¸®´ÐÀÇ ÀÚ¼¼ÇÑ »çÇ×À» º¸½Ç ¼ö ÀÖ½À´Ï´Ù.
Æó¾Ï,µÎ°æºÎ¾Ï,°£´ãµµ¹×ÃéÀå¾ÏŬ¸®´Ð
-
[SCI]
Investigating the feasibility of targeted next-generation sequencing to guide to the treatment of Head and Neck Squamous cell Carcinoma.
Lim SM, Cho SH, Hwang IG, Choi JW, Chang H, Ahn MJ, Park KU, Kim JW, Ko YH, Ahn HK, Cho BC, Nam BH, Chun SH, Hong JH, Kwon JH, Choi JG, K
/ Investigating the feasibility of targeted next-generation sequencing to guide to the treatment of Head and Neck Squamous cell Carcinoma.
/
-
[SCI]
Impact of subsequent chemotherapy on the survival of elderly patients with extensive stage small cell lung cancer.
Kang EJ, Choi YJ, Lee SR, Sung HJ, Kim JS.
/ Impact of subsequent chemotherapy on the survival of elderly patients with extensive stage small cell lung cancer.
/ 2020 Apr 29. doi: 10.3904/kjim.2019.136
/ 202004
-
[SCI]
Osimertinib for Patients With Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Multicenter, Open-Label, Phase II Trial (KCSG-LU15-09)
.Cho JH, Lim SH, An HJ, Kim KH, Park KU, Kang EJ, Choi YH, Ahn MS, Lee MH, Sun JM, Lee SH, Ahn JS, Park K, Ahn MJ.
/ Osimertinib for Patients With Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Multicenter, Open-Label, Phase II Trial (KCSG-LU15-09)
/ 2019 Dec 11:JCO1900931
/ 201912
-
[SCI]
Clinical implications of circulating cell-free DNA quantification and metabolic tumor burden in advanced non-small cell lung cancer.
Hyun MH, Lee ES, Eo JS, Kim S, Kang EJ, Sung JS, Choi YJ, Park KH, Shin SW, Lee SY, Kim YH.
/ Clinical implications of circulating cell-free DNA quantification and metabolic tumor burden in advanced non-small cell lung cancer.
/ 2019 Aug;134:158-166.
/ 201908
-
[SCI]
Pulmonary function is implicated in the prognosis non-small cell lung cancer but not in extended disease small cell lung cancer.
Lee SY, Choi YJ, Seo JH, Lee SY, Kim JS, Kang EJ.
/ Pulmonary function is implicated in the prognosis non-small cell lung cancer but not in extended disease small cell lung cancer.
/ 2019;11(11):4562-4572.
/ 201907